| Literature DB >> 35144660 |
Xiaoqing Zhong1,2, Zhenning Di1,2, Yuanxin Xu1,2, Qifan Liang1,2, Kuanhan Feng1,2, Yuting Zhang1,2, Liuqing Di3,4, Ruoning Wang5,6.
Abstract
Mineral drugs are an important constituent of traditional Chinese medicine (TCM). Taking minerals that contain heavy metals as drugs is a very national characteristic part of TCM. However, the safety and scientific nature of mineral drugs are controversial owing to their heavy metals and strong toxicity. In 2000, the Food and Drug Administration (FDA) authorized arsenic trioxide (ATO) as first-line therapy for acute promyelocytic leukemia. This makes the development and utilization of mineral drugs become a research hotspot. The development of nanomedicine has found a great prospect of mineral drugs in nano-delivery carriers. And that will hold promise to address the numerous biological barriers facing mineral drug formulations. However, the studies on mineral drugs in the delivery system are few at present. There is also a lack of a detailed description of mineral drug delivery systems. In this review, the advanced strategies of mineral drug delivery systems in tumor therapy are summarized. In addition, the therapeutic advantages and research progress of novel mineral drug delivery systems are also discussed. Here, we hope that this will provide a useful reference for the design and application of new mineral drug delivery systems.Entities:
Keywords: Active ingredient; Mineral drug; Novel drug delivery system; Traditional preparation
Year: 2022 PMID: 35144660 PMCID: PMC8830990 DOI: 10.1186/s13020-022-00577-9
Source DB: PubMed Journal: Chin Med ISSN: 1749-8546 Impact factor: 5.455
Fig. 1Schematic diagram of the role that mineral medicines play in modern drug delivery systems. Mineral drugs can function in novel delivery systems as synergistic drugs (A) and drug delivery vehicles (B), respectively. C Mineral drug nanoparticles can penetrate cell membranes and precisely target tumor cells
Fig. 2Illustration of the development process of mineral pharmaceutical preparations. The application of mineral medicine was first recorded in “Shanhaijing”. “Shennong herbal classic” and “Compendium of Materia Medica” have sorted out the mineral medicines. In the twenty-first century, with the development of modern scientific and technological means, people's understanding of mineral drugs has gradually deepened. The FDA's first approval of arsenic trioxide as a first-line anticancer drug is of epoch-making significance. (The
copyright of the pictures from network sources in the figure is shown below. Copyright© 2012–2021 Chengdu Gaoxin bingzhengtang TCM outpatient department Co., Ltd. all rights reserved. Copyright@2014 www.fl2j.com. Copyright© 2013 Phoenix New Media Limited All Rights Reserved. Copyright© 2019 www.tcmdoc.cn. Copyright© 2008–2013 gucn.com. Copyright© 2008 https://www.zhihu.com/. Copyright© https://www.hrhnyy.cn/. Copyright 1996–2006 Cerner Multum, Inc.)
Summary of active components and pharmacological effects of mineral drugs
| Compound | Source | Efficacy indications | Pharmacological activity and mechanism |
|---|---|---|---|
| Mercury | Cinnabar (HgS) | Tranquillization with heavy prescription, improving eyesight, and removing toxicity substances | Conserve dopaminergic neurons from lipopolysaccharide-induced neurotoxicity by suppressing the microglial activation and proinflammatory factor production [ Neuroprotective effect on ischemic stroke and reperfusion injury [ Neuroprotective effect on neurodegenerative diseases [ Reduce oxidative stress by regulating 5-HT metabolism [ |
| Iron | Magnetite (Fe3O4) | Tranquillization with heavy prescription and suppressing hyperactive liver and subsiding yang | Induce apoptosis of A549 lung adenocarcinoma cell line [ |
| Ochre (Fe2O3) | Suppressing hyperactive liver for descending adverse qi and cooling blood for hemostasis | Inhibit the expression of some inflammatory cytokines and interferon response genes, regulate T cell immune activity, and play an anti-inflammatory role [ Induction of TNF in RAW264.7 cells- α and IL-6 expression [ | |
| Calcium | Gypsum (CaSO4·2H2O) | Clearing heat-fire and quenching thirst | Increase the utterance level of Aquaporin-3, accelerate the formation of collagen and capillaries on the wound, and promote the proliferation of granulation tissue, thereby promoting the healing of the skin wound [ |
| Arsenic | Realgar (As2S2) | Killing ascarid and removing toxic substances, eliminating dampness and phlegm, and preventing malaria | Inhibit the proliferation of leukemia cell line F-36P and induce its apoptosis [ Inducing apoptosis of human liver cancer HepG2, QGY-7703 cells and blocking cell cycle G2/M progression [ Inhibit the overexpression of microRNA-372 to restrain the pervasion and diaspora of prostate neoplasm cells [ Prohibition of gastric carcinoma cells metastasis via the NFA Tc3/c-Myc roadway [ Repress the activity of MCF-7 and MDA-MB-231 in human chest cancer cells [ |
| Arsenic trioxide (As2O3) | Eliminating pus and necrotic tissues, dissipating phlegm, and preventing malaria | Induce Molt-4 and Mutz-1 autophagy damage in leukemia cells [ | |
| Aluminum | Alum (KAl (SO4)2·12H2O) | Killing ascarid and removing toxicity substance for external, eliminating phlegm for calming endogenous wind and hemostasis for internal | Reduce the content of collagen in the myometrium, gene representation, and albumen concentration of MMP-2 and MMP-9 to improve uterine leiomyoma [ |
| Halloysite (Al4(Si4O10) (OH)8 · 4H2O) | Astringing sores, promoting granulation and hemostasis | Protect locally inflamed gastrointestinal mucosa | |
| Copper | Blue vitriol (CuSO4·5H2O) | Eliminating necrosis and detoxication | Promote bile secretion and have a sialagogic effect |
| Sodium | Mirabilite (Na2SO4·10H2O) | Clearing heat for detumescence and moistening dryness for relaxing bowels | Promote intestinal activity and improve gastrointestinal dysfunction [ |
| Magnesium | Talc (Mg3(Si4O10) (OH)2) | Clearing heat and freeing strangury | Protect the inflamed gastrointestinal mucosa or damaged skin tissues [ |
A summary of traditional preparations of mineral drugs
| Preparation | Chinese patent medicine | Mineral medicines | Pharmacological action | Clinical application |
|---|---|---|---|---|
| Decoction | Baihu decoction | Gypsum | Clearing heat and promoting fluid production | Viral cold high fever, acute cerebral hemorrhage, infectious diseases, etc |
| Zhengan Xifeng decoction | Os Draconis | Suppressing hyperactive liver for calming endogenous wind and nourishing yin for suppressing hyperactive yang | Hypertension, cerebrovascular disease, chronic gastritis, intractable insomnia, etc | |
| Dachengqi decoction | Mirabilite | Completed under the hot junction | Simple intestinal obstruction, adhesive intestinal obstruction, acute cholecystitis, acute pancreatitis, etc | |
| Bixie Shenshi decoction | Talc | Clearing heat and cooling blood and promoting diuresis | Gout, mycotic vaginitis, acute eczema, erythema nodosum, lower limb erysipelas | |
| Cream soup | Os Draconis | Relieving diarrhea with astringents | Chyluria, etc | |
| Chishizhi Yuyuliang decoction | Halloysite, Limonite | Astringing the intestine and arresting proptosis | Diarrhea, functional uterine bleeding, chronic enteritis, metrorrhagia, etc | |
| Guizhi Gancao Longgu Muli decoction | Os Draconis | Anti-depression, amelioration of menopausal syndrome | Insomnia, spontaneous sweating, night sweats, etc | |
| Jianling decoction | Ochre, Os Draconis | Nourishing yin for tranquillization and suppressing hyperactive liver for calming endogenous wind | Hypertension, cardiac neurosis hemorrhagic sinusitis, migraine, intractable hiccup, etc | |
| Ephedra Almond Licorice Plaster decoction | Gypsum | Antiviral, antipyretic, antitussive, expectorant, diuretic, sedative et al | Community-acquired pneumonia, pediatric acute bronchopneumonia, etc | |
| Zhuling decoction | Talc | Diuretic, antibacterial, improve renal function, inhibit the formation of kidney stones | Recurrent urinary tract infection, ascites due to hepatitis B cirrhosis, brain injury, etc | |
| Daqinjiao decoction | Gypsum | Anti-inflammatory | Gout, rheumatoid arthritis, facial palsy, scapulohumeral periarthritis, etc | |
| Xuanbai Chengqi decoction | Gypsum | Ventilating lung qi for dissipating phlegm and purgation | Pulmonary heart disease, asthma, bronchiectasis, lung abscess, etc | |
| Dahuang Mudan decoction | Mirabilite | Clearing heat for detumescence | Acute simple appendicitis, pelvic inflammation | |
| Xuanfu Daizhe decoction | Ochre | Harmonizing stomach for descending adverse qi | Gastritis, gastric distension, pyloric insufficiency, nervous hiccup, etc | |
| Huanglong decoction | Mirabilite | Clearing intestinal heat, replenishing qi, and nourishing blood | Typhoid fever, epidemic cerebrospinal meningitis, senile intestinal obstruction, etc | |
| Pill | Jiebiao Zhuifeng pills | Cinnabar, Realgar | Dispel wind and dispel exterior, strengthen stomach and balance | Headache with wind-cold and cough |
| Fangfeng Tongsheng pills | Mirabilite, Talc, Gypsum | Relieving superficies and catharsis and clearing heat and removing toxicity | Cold, trigeminal neuralgia, acute shigellosis, acute conjunctivitis, etc | |
| Niuhuang Qingwei pills | Gypsum | Improve gastrointestinal function and has a certain analgesic effect | Tonsillitis, gingivitis, recurrent oral ulcers, acute pharyngitis | |
| Niuhuangzhibao pills | Gypsum, Mirabilite, Realgar | Clearing heat-fire and facitating feces excretion | Functional constipation | |
| Liushen pills | Realgar | Antibacterial, anti-inflammatory, anti-viral, anti-convulsive, sedative, and enhance immunity | Chronic pharyngitis, chronic hepatitis, upper gastrointestinal cancer, leukemia, etc | |
| Jiuzhi Qingxin pills | Cinnabar, Realgar | Clearing heat-fire and facitating feces excretion | Dizziness, mouth and nose sores, sore throat, constipation knots, etc | |
| Liangge pills | Gypsum, Mirabilite | Anti-inflammatory and antipyretic | Sore mouth and tongue, hematemesis, cough, sore throat, etc | |
| Qingwei Huangliang pills | Gypsum | Antipyretic, anti-inflammatory, anti-viral | Stomatitis, periodontitis, and oral ulcer | |
| Huanglian Shangqing pills | Gypsum | Antipyretic, anti-inflammatory, antiviral, analgesic | Acute stomatitis, acute conjunctivitis, acute gastroenteritis, toothache mouth ulcer, etc | |
| Fufang Niuhuang Qingwei pillls | Gypsum, Mirabilite | Antipyretic, anti-inflammatory, and anti-viral | Acute pharyngitis, tonsillitis, oral ulcer, and periodontitis | |
| Daochi pills | Talc | Antibacterial, anti-inflammatory, analgesic, diuretic, antipyretic, anti-platelet aggregation, hemostasis | Stomatitis, urethritis, acute and chronic pyelonephritis, urinary calculi | |
| Jinsuo Gujing pills | Os Draconis | Decrease urine protein, regulate blood lipid and improve pathological changes of renal tissue | Male neurosis effects, chronic cervicitis, intractable night sweats, etc | |
| Wan`s Niuhuang Qingxin pills | Cinnabar | Clearing away the heat-evil and calming down | Japanese encephalitis, pertussis complicated with meningoencephalitis, etc | |
| Niuhuang Qingxin pills | Cinnabar, Realgar | Sedation, anti-convulsion, antipyretic, antihypertensive, improve hypoxia tolerance | Severe amnesia, aphthous stomatitis, intractable hiccups | |
| Angong Niuhuang pills | Cinnabar, Realgar | A calm, strong heart, protect brain tissue, antipyretic, anti-inflammatory, anti-pathogenic microorganisms | Japanese encephalitis, toxic pneumonia, high fever and coma caused by infection or poisoning, etc | |
| Suhexiang pills | Cinnabar | Dilate coronary artery, increase coronary flow, slow heart rate, reduce myocardial oxygen consumption, etc | Coronary heart disease angina, myocardial infarction, acute cerebrovascular disease, epilepsy, etc | |
| Mengshi Guntan pills | Mica-schist | Dispelling phlegm, relieving asthma and sedation, etc | Stroke, schizophrenia, epilepsy, migraines, neurosis effects | |
| Medical pills | Cinnabar, Realgar, Alum | Sedation, analgesia, anticonvulsants, etc | Epilepsy, manic psychosis | |
| Baizi Yangxin pills | Cinnabar | Inhibit the central nervous and play sedation, hypnosis, diazepam, anti-convulsion | Neurasthenia, memory loss, schizophrenia, menopause, hyperthyroidism, heart disease, etc | |
| Cizhu pills | Magnetite, Cinnabar | Nourishing blood for improving eyesight and tranquillization | For epilepsy, tinnitus, insomnia, and so on | |
| Tianwang Buxin pills | Cinnabar | Anti-myocardial infarction, enhance the body’s immune function, sedation, anti-convulsion, anti-arrhythmia, etc | Low blood pressure, insomnia, psychosis, hyperthyroidism, climacteric syndrome, chronic conjunctivitis, myocarditis, tuberculosis, hypertension, etc | |
| Zhusha Anshen pills | Cinnabar | Sedative-hypnotic, antiarrhythmic, anticonvulsant, antipyretic and analgesic, etc | Neurasthenia, schizophrenia, epilepsy, myocarditis, etc | |
| Naoliqing pills | Magnetite, Ochre | Lower blood pressure, sedation, antiemetic, vasodilator, etc | High blood pressure, arteriosclerosis, etc | |
| Zaizao pills | Cinnabar | Anti-coagulation, improve microcirculation, anti-inflammation, etc | Stroke, hemiplegia, numbness of hands and feet, pain and convulsion, etc | |
| Gejie Dingchuan pills | Gypsum | Antitussive, expectorant, anti-asthmatic, anti-inflammatory, antibacterial, enhance immune function | Bronchitis, asthma, tuberculosis, etc | |
| Suoyang Gujing pills | Os Draconis, Halite | Treatment of kidney deficiency | Male sexual neurosis effects, prostatitis, infertility, etc | |
| Shixiang Fansheng pills | Cinnabar, Mica-schist | Dissipating phlegm for resuscitation and tranquillization | Hysteria, neurosis effects, shock, epilepsy, schizophrenia, depression, seizures, etc | |
| Powder | Liuyi powder | Talc | Clear away heat and facilitate urination | Heat and dampness caused by fever, external treatment of prickly heat, etc |
| Qili powder | Cinnabar | Remove stasis and detumescence, relieve pain and stop bleeding | Soft tissue injury, and other infectious, purulent diseases, etc | |
| Zixue powder | Gypsum, Talc, Magnetite, Cinnabar, Mirabilite, North Calcium | Antipyretic, anticonvulsant, sedative, antibacterial, anti-inflammatory | Japanese encephalitis, sepsis, acute zinc phosphide poisoning, etc | |
| Biwen powder | Cinnabar | Get rid of the heat and the pain | Summer heat stroke, motion sickness, seasickness | |
| Bingpeng powder | Cinnabar, Borax, Sodium sulfate powder | Anti-inflammatory, anti-fungal, analgesic, etc | Gingival swelling and pain, tonsillitis, oral ulcers, mumps, herpes zoster, fungal vaginitis, and cervical erosion |
Fig. 3Schematic illustration showing the pharmacological activity of mineral drugs and their advantages in tumor treatment. (The
copyright of the pictures from network sources in the figure is shown below. Copyright© 2021 Sohu All Rights Reserved. Copyright©1997–2021 https://www.163.com/.)
Novel preparations of mineral drugs and preclinical study
| Register number | Study title | Conditions | Interventions/drugs | Locations |
|---|---|---|---|---|
| NCT04687176 | Frontline oral arsenic trioxide for APL | APL | Dru: oral arsenic trioxide formulation | The University of Hong Kong |
| NCT03624270 | Oral arsenic trioxide for newly diagnosed acute promyelocytic | APL | Drug: oral arsenic trioxide, all-trans retinoic acid, and ascorbic acid | The University of Hong Kong |
| NCT04689815 | Oral arsenic trioxide for nucleophosmin 1 mutated acute myeloid leukemia (AML) | AML | Drug: oral arsenic trioxide formulation | The University of Hong Kong |
| NCT04634838 | Efficacy dressings with copper oxide | Pressure ulcer | Device: medcu antibacterial wound dressings with copper oxide | Loewenstein Rehabilitation Center ra'anana, Israel |
| NCT01565798 | Efficacy of copper to reduce acquisition of microbes and healthcare-acquired infections | Healthcare-acquired infection | Other: copper-alloy surfaced patient care objects | Medical University of South Carolina |
| NCT01678612 | Efficacy of copper in reducing health-acquired infections in a pediatric intensive care unit | Nosocomial infections | Copper-alloy surfaced objects | Hospital Roberto del Rio, Santiago, Chile |
| NCT03323346 | Phase II trial of disulfiram with copper in metastatic breast cancer | Breast neoplasm female | Drug: disulfiram | University hospital Olomouc, Olomouc, Czechia |
| NCT03284749 | Effect of copper on the healing of obstetric wounds | Cesarean section and infection | Other: copper impregnated wound dressing, and normal wound dressing | Croydon health services NHS trust |
| NCT04511468 | Zinc, chromium, vitamin C, and copper combination supplement for prediabetes progression | Prediabetes | Dietary supplement: zinc, chromium, vitamin C, and copper supplementation, and placebo | Human Nutrition Research Center |
| NCT01777919 | Disulfiram/copper combination in the treatment of newly diagnosed glioblastoma multiform | Glioblastoma multiforme | Temozolomide, disulfiram, copper | Olympion medical Center, Patras, Greece |
| NCT00608946 | Treatment with copper in patients with mild Alzheimer’s dementia | Alzheimer’s disease | Dietary supplement: copper | |
| NCT03736109 | Role of a copper-albumin complex in the treatment of knee osteoarthritis in human | Osteo arthritis knee | Genetic: soluble and genetic biomarkers measurements | |
| NCT02715609 | Disulfiram/copper with concurrent radiation therapy and temozolomide in patients with newly diagnosed glioblastoma | Glioblastoma multiforme | Drug: disulfiram, and copper gluconate | Washington University school of medicine, Saint Louis, Missouri, United States |
| NCT01017315 | Efficacy of baby talcum in the prevention of pruritus assosiated with cast | Fracture distal radius | Drug: baby talcum | Prince of Songkhla university |
| NCT04792970 | Randomized controlled trial of talc instillation in addition to daily drainage through a tunneled pleural catheter to improve rates of outpatient pleurodesis in patients with malignant pleural | Malignant pleural effusion | Drug: talc | Duke University Medical center, Durham, North Carolina, United States |
| NCT00789087 | Talc pleurodesis in patients with recurrent malignant pleural effusion | Recurrent malignant pleural effusion | Procedure: video thoracoscopic talc poudrage, and talc slurry through a chest tube | University of são Paulo medical school |
| NCT03635138 | Effect of the incoportation of copper and zinc nanoparticles into dental adhesives | Caries, dental | Other: metal nanoparticles (Zn and Cu), and dental adhesive pure | Eduardo Fernández G, Santiago, Metropolitana |
| NCT04775238 | Effect of metallic nanoparticles on nosocomial bacteria | Nosocomial infections | Other: silver nanoparticles, and copper nanoparticles | Faculty of medicine-sohag University, Sohag, Egypt |
| NCT02200978 | A study for improving the outcome of childhood acute promyeloid leukemia | Childhood acute promyelocytic leukemia | Drug: indigo naturalis formula, and ATO, ATRA (and 5 more…) | The first affiliated hospital of Sun Yat-Sen University |
| NCT04489706 | Arsenic trioxide in recurrent and metastatic ovarian cancer and endometrial cancer with P53 mutation | Ovarian cancer | Drug: arsenic trioxide for injection | Shanghai Jiaotong university school of medicine affliated ruijin hospital |
| NCT02966301 | Treatment of chronic graft versus host disease with arsenic trioxide | Chronic graft-versus-host disease | Drug: arsenic trioxide injectable solution | CHU de caen-institut d'Hématologie de basse normandie |
| NCT01470248 | Study of arsenic trioxide in small cell lung cancer | Lung cancer | Drug: arsenic trioxide | Emory University Winship Cancer institute |
| NCT01791894 | Arsenic trioxide in treating patients with basal cell carcinoma | Basal cell carcinoma of the skin | Drug: arsenic trioxide | Stanford university medical center |
| NCT03751917 | Long-term safety study of arsenic trioxide in newly diagnosed, low-to-intermediate risk acute promyelocytic leukemia | Acute promyelocytic leukemia | Drug: Arsenic Trioxide | Aon Ss. Antonio E Biagio E C. Arrigo-Alessandria-soc ematologia,Alessandria, Italy |
| NCT00009867 | Arsenic trioxide in treating patients with urothelial cancer | Recurrent transitional cell cancer of the renal pelvis and ureter | Drug: arsenic trioxide | Cancer and leukemia group B |
| NCT00024258 | Arsenic trioxide in treating patients with advanced neuroblastoma or other childhood solid tumors | Brain and central nervous system tumors | Drug: arsenic trioxide | Memorial Sloan-Kettering Cancer Center, New York |
| NCT00008697 | Arsenic trioxide in treating patients with refractory or recurrent acute promyelocytic leukemia | Leukemia | Drug: arsenic trioxide | Washington university school of medicine |
| NCT00045565 | Arsenic trioxide plus radiation therapy in treating patients with newly diagnosed malignant glioma | Adult giant cell glioblastoma | Drug: arsenic trioxide | New approaches to brain tumor therapy consortium, Baltimore |
| NCT00517712 | Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia | Acute promyelocytic leukemia | Drug: single-agent arsenic trioxide | Kidwai memorial institute of oncology, India |
| NCT00053222 | Arsenic trioxide in treating patients with pancreatic cancer that has not responded to gemcitabine | Pancreatic cancer | Drug: arsenic trioxide | Decatur memorial hospital cancer care institute, Decatur, Illinois, United States |
| NCT00193518 | Arsenic trioxide in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma | Chronic lymphocytic leukemia | Drug: arsenic trioxide | Tennessee Oncology, Nashville, Tennessee, United States |
| NCT00128596 | Arsenic trioxide in treating patients with metastatic liver cancer that cannot be removed by surgery | Liver cancer | Drug: arsenic trioxide | UPMC cancer centers, Pittsburgh, Pennsylvania, United States |
| NCT00003630 | Arsenic trioxide in treating patients with advanced solid tumors | Unspecified adult solid tumor, protocol-specific | Drug: arsenic trioxide | Memorial Sloan-Kettering cancer center, New York |
| NCT00075426 | Arsenic trioxide in treating patients with locally advanced or metastatic non-small cell lung cancer | Lung cancer | Drug: arsenic trioxide | University of texas medical branch |
| NCT00005069 | Arsenic trioxide in treating patients with metastatic kidney cancer | Kidney cancer | Drug: arsenic trioxide | Memorial Sloan-Kettering cancer center New York |
| NCT00005040 | Arsenic trioxide in treating patients with relapsed or refractory non-Hodgkin's lymphoma | Lymphoma | Drug: arsenic trioxide | Memorial Sloan-Kettering cancer center New York |
| NCT00036842 | Arsenic trioxide in treating men with germ cell cancer | Extragonadal germ cell tumor testicular germ cell tumor | Drug: arsenic trioxide | MBCCOP-Gulf coast mobile, Alabama, United States |
| NCT03503864 | Phase II study of combined chemotherapy with arsenic trioxide in stage 4/M neuroblastoma | Neuroblastoma | Drug: arsenic trioxide | Sun Yat-sen memorial hospital, Sun Yat-sen University |
| NCT04869475 | Arsenic trioxide in refractory solid tumors with rescuable p53 mutation | Refractory solid tumors | Drug: arsenic trioxide | Department of Oncology, Ruijin hospital |
| NCT00621023 | Cephalon decitabine, arsenic trioxide, and ascorbic acid for myelodysplastic syndrome | Myelodysplastic syndrome | Drug: decitabine, arsenic trioxide, and ascorbic acid | Duke university medical center |
Fig. 4A Schematic illustration of the synthesis of MnAs@SiO2-pHLIPs and their functions in the tumor. After treating SMMC-7721 cancer cells with MnAs@SiO2 and MnAs@SiO2-pHLIP, the total amount of Mn ions (B) and As ions (C) in the cells at pH 7.4 and pH 6.0. F Flow cytometric analysis of SMMC-7721 cells incubated with different drugs for 2 h at different pH. SMMC-7721 cells served with free ATO, MnAs @ SiO2, and MnAs @ SiO2 pHLIP at pH 7.4. D And the cell viability at pH 6.0 (E) and pH 7.4. (n = 6) [40]
Copyright 2019, Royal Society of Chemistry. G Fluorescence microscopy images of prepared oligopeptide nanoparticles in HUVEC cells (scale bar:200 μM). [41] Copyright 2020, Elsevier
Fig. 5A Schematic illustration for the synthesis and preparation of ANG-LP-PAA-MSN@ATO for glioma therapy. B Confocal images of HBMEC cells and C6 cells treated with the three agents for 4 h [48].
Copyright 2019, American Chemical Society. C Schematic represented for ATO liposome modified with Ac4MAN micelle. D Drug release curves of ATO-LIP and Ac4MAN-ATo-LIP (E) drug release curves of Ni-LIP and Ac4MAN-Ni-LIP (n = 3) [49]. Copyright 2019, American Chemical Society. F Tumor growth curves after treatment with the same dose of dimethyl sulfoxide, GANT, ATO, Gos, GANT/Gos, and ATO/Gos at 2.5 µM. G Bar charts made at 6, 13, and 28 days [50]. Copyright 2019, MDPI
Fig. 6A Construction of the composite nanodrug delivery system. B JC-1 mitochondrial membrane potential staining (200×). Cell migration (C), proliferation (D), and apoptosis (E) test results after treatment with the composite nanoparticles [61].
Copyright 2020, American Chemical Society. F The synthesis scheme of As2O3-PLGA/PLC NPs. IC50 values of the nanoparticles against LO2 and SMMC-7721 cells after 24 (G), 48 (H), and 72 (I) h incubation (mean ± SD, n = 5) [3]. Copyright 2019, Elsevier
Fig. 7A Schematic of the preparation of ATF-IONP-Gem. B Drug release condition and efficiency. IONPs, IONP-Gem, ATF-IONP-Gem, and human pancreatic cancer cells were incubated in 100 nm and 10 nm for 4 h, then Prussian blue staining was performed. C IONPs in cells were detected as blue-stained cells. D the OD value was quantitatively detected at 680 nm with a micro board reader. E The observed bright-field microscopic images of Prussian blue-stained cells under 40 × magnifications of. F the number of living cells per well in a 96-well tissue culture plate was determined by the MTT method [76].
Copyright 2013, American Chemical Society. G The drug loading rate of synthetic liposomes was determined by inductively coupled plasma optical emission spectrometry (ICP-OES) at different particle sizes and (H) different charges [64]. Copyright 2019, MDPI
Fig. 8Schematic synthesis of mineral drug nanocarrier. The schematic diagram shows the application of magnetic nanoparticles, magnetic lipid complexes, magnetic microsphere systems, and percutaneous administration in mineral drug delivery systems. (The pictures in the figure from network sources have been allowed.
Copyright© 2014–2021 588ku.com. Copyright© 2011–2021 ZHONGYIBAIKE.COM All rights reserved. Copyright© 2019 www.tcmdoc.cn.)